Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Viridian Therapeutics, Inc.\DE | Chief Medical Officer | Stock Option (Right to Buy) | 108K | Feb 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics, Inc.\DE | Feb 8, 2023 | 1 | $0 | 4 | Feb 10, 2023 | Chief Medical Officer |
VRDN | Viridian Therapeutics, Inc.\DE | Jan 13, 2023 | 6 | -$410K | 4 | Jan 18, 2023 | Chief Medical Officer |
VRDN | Viridian Therapeutics, Inc.\DE | Jan 9, 2023 | 6 | -$708K | 4 | Jan 11, 2023 | Chief Medical Officer |
VRDN | Viridian Therapeutics, Inc.\DE | Feb 2, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Chief Medical Officer |